Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALISKIREN HEMIFUMARATE Cause Muscular weakness? 184 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 184 reports of Muscular weakness have been filed in association with ALISKIREN HEMIFUMARATE (Aliskiren). This represents 36.4% of all adverse event reports for ALISKIREN HEMIFUMARATE.

184
Reports of Muscular weakness with ALISKIREN HEMIFUMARATE
36.4%
of all ALISKIREN HEMIFUMARATE reports
0
Deaths
175
Hospitalizations

How Dangerous Is Muscular weakness From ALISKIREN HEMIFUMARATE?

Of the 184 reports, 175 (95.1%) required hospitalization, and 165 (89.7%) were considered life-threatening.

Is Muscular weakness Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALISKIREN HEMIFUMARATE. However, 184 reports have been filed with the FAERS database.

What Other Side Effects Does ALISKIREN HEMIFUMARATE Cause?

Nausea (227) Fall (214) Cerebrovascular accident (196) Anxiety (195) Fatigue (186) Confusional state (185) Hemiparesis (181) Hemiplegia (181) Muscle spasticity (181) Personality disorder (181)

What Other Drugs Cause Muscular weakness?

ADALIMUMAB (3,605) METHOTREXATE (2,813) RITUXIMAB (2,621) ATORVASTATIN (2,494) PREDNISONE (2,236) ETANERCEPT (2,207) DALFAMPRIDINE (1,916) TOCILIZUMAB (1,790) FINGOLIMOD (1,769) SECUKINUMAB (1,747)

Which ALISKIREN HEMIFUMARATE Alternatives Have Lower Muscular weakness Risk?

ALISKIREN HEMIFUMARATE vs ALISKIREN\HYDROCHLOROTHIAZIDE ALISKIREN HEMIFUMARATE vs ALIZAPRIDE ALISKIREN HEMIFUMARATE vs ALLANTOIN ALISKIREN HEMIFUMARATE vs ALLEGRA ALISKIREN HEMIFUMARATE vs ALLEGRA 24 HOUR

Related Pages

ALISKIREN HEMIFUMARATE Full Profile All Muscular weakness Reports All Drugs Causing Muscular weakness ALISKIREN HEMIFUMARATE Demographics